QSM Asset Management Ltd bought a new stake in Axcelis Technologies, Inc. (NASDAQ:ACLS - Free Report) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 60,416 shares of the semiconductor company's stock, valued at approximately $4,222,000. Axcelis Technologies accounts for approximately 3.9% of QSM Asset Management Ltd's portfolio, making the stock its 14th biggest position. QSM Asset Management Ltd owned approximately 0.19% of Axcelis Technologies at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. MassMutual Private Wealth & Trust FSB grew its position in Axcelis Technologies by 50.3% in the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 481 shares of the semiconductor company's stock valued at $34,000 after buying an additional 161 shares during the last quarter. Parallel Advisors LLC grew its position in Axcelis Technologies by 129.0% in the 2nd quarter. Parallel Advisors LLC now owns 545 shares of the semiconductor company's stock valued at $38,000 after buying an additional 307 shares during the last quarter. Fifth Third Bancorp grew its position in Axcelis Technologies by 160.5% in the 1st quarter. Fifth Third Bancorp now owns 581 shares of the semiconductor company's stock valued at $29,000 after buying an additional 358 shares during the last quarter. Versant Capital Management Inc grew its position in Axcelis Technologies by 118.7% in the 1st quarter. Versant Capital Management Inc now owns 584 shares of the semiconductor company's stock valued at $29,000 after buying an additional 317 shares during the last quarter. Finally, Bayforest Capital Ltd purchased a new stake in shares of Axcelis Technologies during the 1st quarter worth $38,000. 89.98% of the stock is currently owned by hedge funds and other institutional investors.
Axcelis Technologies Trading Up 5.0%
NASDAQ ACLS opened at $100.44 on Tuesday. Axcelis Technologies, Inc. has a 12 month low of $40.40 and a 12 month high of $110.17. The company has a 50-day moving average of $79.81 and a 200-day moving average of $65.89. The company has a debt-to-equity ratio of 0.04, a current ratio of 6.01 and a quick ratio of 4.26. The company has a market cap of $3.16 billion, a P/E ratio of 20.54 and a beta of 1.73.
Axcelis Technologies (NASDAQ:ACLS - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The semiconductor company reported $1.13 EPS for the quarter, beating analysts' consensus estimates of $0.73 by $0.40. Axcelis Technologies had a net margin of 17.69% and a return on equity of 16.26%. The company had revenue of $194.54 million during the quarter, compared to the consensus estimate of $185.15 million. During the same quarter in the prior year, the company posted $1.55 EPS. The company's quarterly revenue was down 24.2% compared to the same quarter last year. Axcelis Technologies has set its Q3 2025 guidance at 1.000-1.000 EPS. As a group, equities analysts predict that Axcelis Technologies, Inc. will post 2.55 earnings per share for the current year.
Analysts Set New Price Targets
ACLS has been the subject of a number of research analyst reports. DA Davidson increased their target price on shares of Axcelis Technologies from $75.00 to $90.00 and gave the company a "buy" rating in a report on Wednesday, August 6th. B. Riley upped their price target on Axcelis Technologies from $58.00 to $75.00 and gave the stock a "neutral" rating in a report on Wednesday, June 18th. Two equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $90.00.
Get Our Latest Report on ACLS
About Axcelis Technologies
(
Free Report)
Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Axcelis Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axcelis Technologies wasn't on the list.
While Axcelis Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.